Prognostic and predictive impact of cytogenetic changes in relapsed multiple myeloma patients treated with bortezomib or thalidomid based regiments: a Czech group experience

Authors

SMETANA Jan KUGLÍK Petr GREŠLIKOVÁ Henrieta KUPSKÁ Renata NĚMEC Pavel BERÁNKOVÁ Kristina ZAORALOVÁ Romana FILKOVÁ Hana POUR Luděk KREJČÍ Marta ZAHRADOVÁ Lenka HOLÁNEK Michal ADAM Zdeněk HÁJEK Roman

Year of publication 2010
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info